ESC Professional Premium Access

Long-term clinical-pathologic results of enzyme replacement therapy in pre-hypertrophic Fabry disease cardiomyopathy

Congress Presentation

About the speaker

Doctor Andrea Frustaci

INMI Lazzaro Spallanzani Scientific Institute for Research and Healthcare, Rome (Italy)
4 presentations
0 follower

6 more presentations in this session

Association between dapagliflozin, cardiac biomarkers, and cardiac remodeling in patients with diabetes mellitus and heart failure: a post-hoc analysis of a randomized study

Speaker: Doctor A. Xanthopoulos (Larissa, GR)


Biomarker profiles of favorable ventricular remodeling in heart failure patients with reduced ejection fraction: Insights from the echocardiographic substudy of the VICTORIA trial

Speaker: Doctor J. Tromp (Singapore, SG)


Intravenous iron administration in patients with heart failure alters endothelial homeostasis with early release of endothelial microvesicles and subsequent mobilization of endothelial progenitor cell

Speaker: Doctor S. Mause (Aachen, DE)


Effects of percutaneous coronary intervention on improvement of left ventricular ejection fraction among chronic coronary syndrome patients with left ventricular systolic dysfunction

Speaker: Doctor L. Qiao (Guangzhou, CN)


Functional mitral regurgitation and ventricular arrhythmias in patients with cardiac resynchronization therapy

Speaker: Doctor A. Yoshimura (Tokyo, JP)


Access the full session

Pathophysiology of heart failure: effects of interventions

Speakers: Doctor A. Frustaci, Doctor A. Xanthopoulos, Doctor J. Tromp, Doctor S. Mause, Doctor L. Qiao...

About the event


ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by